Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
about
Annotation and evolutionary relationships of a small regulatory RNA gene micF and its target ompF in Yersinia speciesNorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomesAntibiotic resistance: a current perspective.Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureusRole of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: active efflux as a contributing factor to beta-lactam resistance.Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICsEfflux-mediated resistance to fluoroquinolones in gram-negative bacteriaAn imported enteric fever caused by a quinolone-resistant Salmonella Typhi.Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.Evidence for an efflux pump in multidrug-resistant Campylobacter jejuniDetection of mutations in parC in quinolone-resistant clinical isolates of Escherichia coli.Resistance to fluoroquinolones in Escherichia coli isolated from poultry.Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.Activation of multiple antibiotic resistance and binding of stress-inducible promoters by Escherichia coli Rob protein.The Salmonella typhimurium mar locus: molecular and genetic analyses and assessment of its role in virulence.Ciprofloxacin resistance in clinical isolates of Salmonella typhimurium obtained from two patientsPenetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples.Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitro.Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.Genetics and regulation of outer membrane protein expression by quinolone resistance loci nfxB, nfxC, and cfxBQuinolone accumulation in Escherichia coli, Pseudomonas aeruginosa, and Staphylococcus aureus.Reduced susceptibilities of Shigella sonnei strains isolated from patients with dysentery to fluoroquinolones.Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon.Clinical response and outcome of infection with Salmonella enterica serotype Typhi with decreased susceptibility to fluoroquinolones: a United States foodnet multicenter retrospective cohort study.Mechanisms of quinolone resistance in a clinical isolate of Escherichia coli highly resistant to fluoroquinolones but susceptible to nalidixic acidOverexpression of the MarA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli.Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli.Cloning of multidrug resistance gene pqrA from Proteus vulgaris.nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.Intracellular accumulation of norfloxacin in Mycobacterium smegmatisIn vitro activity of AT-4140 against quinolone- and methicillin-resistant Staphylococcus aureus.Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium.Posttranscriptional repression of Escherichia coli OmpF protein in response to redox stress: positive control of the micF antisense RNA by the soxRS locus.Activation of oxidative stress genes by mutations at the soxQ/cfxB/marA locus of Escherichia coliUptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus.Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.Mechanisms of clinical resistance to fluoroquinolones in Enterococcus faecalis.
P2860
Q21263095-7DE406D7-3544-401B-9E87-C8B6CFCE082DQ33183378-F6A89F0F-1095-4CC8-ACBD-0DDC0ADEC5F8Q33693954-23CB67F6-3597-4F97-98E1-E862C338D0D8Q33745800-365B6808-EFDB-4864-92CE-03CB822CA30DQ33756505-732117D8-4EC3-465D-AC5C-D6C8A78A148FQ33762110-921E06C3-6FAE-4713-85CF-C4E6B4B08F91Q34010692-15BD898B-8CA4-4A59-99DC-F8115EC2A73AQ34099282-642AF43A-A707-44CC-BE79-5249336E058DQ34977654-DEB7FA78-B7F1-46D0-9D1F-7E3C761C188AQ35118353-5287D88B-BDD9-4180-9BFF-EC23544FE343Q35122643-56E1201A-3947-4D11-B0C5-5CF3EA4AC265Q35125114-108356C2-75ED-4D0A-87AA-695F92D4A047Q35343881-73AFDDE1-D58B-498A-897C-4E339E8780B1Q35581659-2148156B-67BC-4145-9E5A-079A88EBDF8EQ35620892-073C16A4-23CB-484E-9BB2-1D005980C8DEQ35810998-69CE5131-6E67-4E6E-8883-C543497894FAQ35816625-06963F7A-4B45-486C-BEF1-0F645F5F0595Q35821472-25EBF210-50A8-46C7-BE82-D3EF6F6C0858Q35821659-D8DBA8C8-5805-45A7-82E6-C9116F44C6BEQ35836816-95BCB7BE-07E7-4FC4-9CFF-4FBE465AE287Q35893473-36345C61-87E3-4CA9-86FB-1B6EBC75ABB6Q35900349-381B03F3-30F4-451B-92ED-98E6A4B0A8FFQ36123973-75A74441-02F3-4966-B2E6-F5224F42DBDAQ36538683-BC31C4CF-8155-4B89-A755-E79473EDA664Q36753126-E1732C53-E14F-45AA-A3C0-09E0EE2C7AC4Q36782635-55F2CF06-64B8-4474-8E92-AFA4CB17D8CDQ39487859-77E5EEA6-AD3D-4E30-9766-9AC0405DA868Q39779161-1BE3F0E8-38DA-47D8-9FDF-6A0F993B375AQ39779448-C8C1B6A9-994E-4E75-A2F8-251E70B8A374Q39780132-E5FC4742-2EAA-4F03-9EA9-B98FC0738F01Q39780762-6C19BD69-42D2-41ED-8A64-F4A3CA7A5976Q39816200-5943A6B3-C161-47F0-A8F3-7FE67A94C8EBQ39819849-1C7C4E66-E754-429B-B53B-3E790AE4102EQ39882625-EED3C3FF-343C-4924-8A5F-595134AD96E3Q39884580-31ADD8A7-AC44-4CCC-89E2-5E1E2B33AD86Q39942365-4068CBEB-2ED8-45B6-889E-C06E6A5BCD4FQ40085920-AAE19898-A434-4E2A-8D08-DFB0530D43AEQ40088128-9925D978-523C-4805-87B9-3F3614CB3E97Q40088314-9CE78118-3FA5-4037-92CD-72FC222097C6Q40284197-5CFB0B18-EB57-4CDC-81AB-F834E851BD3D
P2860
Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@ast
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@en
type
label
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@ast
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@en
prefLabel
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@ast
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@en
P2093
P2860
P356
P1476
Mechanisms of quinolone resist ...... sing norfloxacin accumulation.
@en
P2093
P2860
P304
P356
10.1128/AAC.33.3.283
P407
P577
1989-03-01T00:00:00Z